Sutro Biopharma Inc buy Piper Sandler
Start price
16.06.25
/
50%
€0.72
Target price
16.06.26
€1.73
Performance (%)
-12.78%
Price
02.12.25
€0.62
Summary
This prediction is currently active. The price of Sutro Biopharma Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.78%. This prediction currently runs until 16.06.26. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Sutro Biopharma Inc | - | - |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Piper_Sandler for this prediction
In the thread Sutro Biopharma Inc diskutieren
Sutro Biopharma, Inc. (NASDAQ: STRO) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $2.00 price target on the stock.
Ratings data for STRO provided by MarketBeat
Stopped prediction by Piper_Sandler for Sutro Biopharma Inc
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€3.48
11.10.24
11.10.24
€10.05
11.10.25
11.10.25
-80.22%
12.10.25
12.10.25
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€4.78
03.04.24
03.04.24
€10.16
03.04.25
03.04.25
-88.81%
04.04.25
04.04.25
Sutro Biopharma Inc
Start price
Target price
Perf. (%)
€2.28
15.11.23
15.11.23
€11.04
15.11.24
15.11.24
18.42%
16.11.24
16.11.24